- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 639-653 of
1,371 results
2032 Exhibit: JSN 2032 Strother et al, Novel cytotoxic and biological agents for pro...
Document
IPR2016-01582, No. 2032-113 Exhibit - JSN 2032 Strother et al, Novel cytotoxic and biological agents for prostate cancer Where will the money be in 2005, European Journal of Cancer, 41954 9...
|
|
Cite Document
2117 Exhibit: JSN 2117 Williams, Discontinued Drugs in 2008 oncology drugs, Expe...
Document
IPR2016-01582, No. 2117-194 Exhibit - JSN 2117 Williams, Discontinued Drugs in 2008 oncology drugs, Expert Opinion on Investigational Drugs, 18111581 1594 2009 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2022 Exhibit: JSN 2022 Debruyne and Witjes, Ketoconazole High Dose HD In The M...
Document
IPR2016-01582, No. 2022-103 Exhibit - JSN 2022 Debruyne and Witjes, Ketoconazole High Dose HD In The Management Of Metastatic Prostatic Carcinoma, The Journal of Urology, 1354, pt220...
|
|
Cite Document
2025 Exhibit: JSN 2025 Conde and Aronson, Risk factors for male osteoporosis, Ur...
Document
IPR2016-01582, No. 2025-106 Exhibit - JSN 2025 Conde and Aronson, Risk factors for male osteoporosis, Urologic Oncology, 21380 383 2003 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2069 Exhibit: JSN 2069 Seale and Compton, Side effects of corticosteroid agents,,...
Document
IPR2016-01582, No. 2069-148 Exhibit - JSN 2069 Seale and Compton, Side effects of corticosteroid agents,, Med J of Australia, 1443139 142 1986 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2099 Exhibit: JSN 2099 CancerNet September 8, 2014 Treatment of Metastatic Cas...
Document
IPR2016-01582, No. 2099-176 Exhibit - JSN 2099 CancerNet September 8, 2014 Treatment of Metastatic Castration Resistant Prostate Cancer (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2116 Exhibit: JSN 2116 Williams, Discontinued Drugs in 2007 oncology drugs, Expe...
Document
IPR2016-01582, No. 2116-193 Exhibit - JSN 2116 Williams, Discontinued Drugs in 2007 oncology drugs, Expert Opinion on Investigational Drugs, 17121791 1816 2008 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2167 Exhibit: JSN 2167 June 4, 2013 Response to Office Action from prosecution h...
Document
IPR2016-01582, No. 2167-236 Exhibit - JSN 2167 June 4, 2013 Response to Office Action from prosecution history of 438 patent (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2024 Exhibit: JSN 2024 Krishnan et al, A Glucocorticoid Responsive Mutant Androg...
Document
IPR2016-01582, No. 2024-105 Exhibit - JSN 2024 Krishnan et al, A Glucocorticoid Responsive Mutant Androgen Receptor Exhibits Unique Ligand Specificity TherapeuticImplications for Androge...
|
|
Cite Document
2164 Exhibit: JSN 2164 July 3, 2013 Notice of Allowance from prosecution history o...
Document
IPR2016-01582, No. 2164-233 Exhibit - JSN 2164 July 3, 2013 Notice of Allowance from prosecution history of438 patent (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2023 Exhibit: JSN 2023 Herr and Pfitzenmaier, Glucocorticoid use in prostate canc...
Document
IPR2016-01582, No. 2023-104 Exhibit - JSN 2023 Herr and Pfitzenmaier, Glucocorticoid use in prostate cancer and other solid tumours implications for effectiveness of cytotoxictreatment and m...
|
|
Cite Document
2156 Exhibit: JSN 2156 Sartor, The Continuing Challenge of Hormone Refractory P...
Document
IPR2016-01582, No. 2156-225 Exhibit - JSN 2156 Sartor, The Continuing Challenge of Hormone Refractory Prostate (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2079 Exhibit: JSN 2079 Carducci et al, A Phase 3 Randomized Controlled Trial of th...
Document
IPR2016-01582, No. 2079-158 Exhibit - JSN 2079 Carducci et al, A Phase 3 Randomized Controlled Trial of the Efficacy and Safety of Atrasentan in Men With Metastatic Hormone refractory Pros...
|
|
Cite Document
2163 Exhibit: JSN 2163 Sweeney, et al, Chemohormonal Therapy in Metastatic Hor...
Document
IPR2016-01582, No. 2163-232 Exhibit - JSN 2163 Sweeney, et al, Chemohormonal Therapy in Metastatic Hormone Sensitive Prostate Cancer, NEJM, 373737 746 2015 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2111 Exhibit: JSN 2111 Duc et al, In vitro and in vivo models for the evaluation of po...
Document
IPR2016-01582, No. 2111-188 Exhibit - JSN 2111 Duc et al, In vitro and in vivo models for the evaluation of potent inhibitors of male rat for the 17 hydroxylaseC17,20 lyase, Journal of Steroid Bio...
|
|
Cite Document
